Today’s big question for investors is, “what’s going on with Safeguard Scientifics, Inc. (NYSE:SFE) stock? Its price is jumping 0.51 points, trading at $12.05 levels, and is up 4.41% from its previous close of $11.54. The shares seem to have an active trading volume day with a reported 153763 contracts so far this session. SFE shares had a relatively better volume day versus average trading capacity of 71.17 million shares, but with a 18.92 million float and a -1.2% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for SFE stock indicates that the average analyst price target is $14.3 per share. This means the stock has a potential increase of 18.67% from where the SFE share price has been trading recently which is between $11.34 and $11.65. There are some brokerage firms that offer lower targets than the average, with one of them, even setting their price target at $12.
The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Safeguard Scientifics’ Partner Company Transactis Acquired by Mastercard” and dated May 17, 2019.
During the recent trading session for Safeguard Scientifics, Inc. (NYSE:SFE), the company witnessed their stock rise $0.35 over a week and surge $1.02 from the price 20 days ago. When compared to their established 52-week high of $13.6, the high they recorded in their recent session happens to be lower. Their established 52-week high was attained by the company on 06/12/18. The recent low of $7.98 stood for a -11.41% since 11/16/18, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 1.05 is also allocated to the stock. Since the beta is greater than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.
Looking at the current readings for Safeguard Scientifics, Inc., the two-week RSI stands at 68.49. This figure suggests that SFE stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current SFE readings is similarly very revealing as it has a stochastic reading of 60.71% at this stage. This figure means that SFE share price today is being neutral.
Technical chart claims that Safeguard Scientifics, Inc. (SFE) would settle between $11.68/share to $11.82/share level. However, if the stock price goes below the $11.37 mark, then the market for Safeguard Scientifics, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $11.2 for its downside target. The stock is currently in the green zone of MACD, with the indicator reading 0.01. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at First Analysis Sec lowered their recommendation on shares of SFE from Overweight to Equal-Weight in their opinion released on July 27. Keefe Bruyette, analysts launched coverage of Safeguard Scientifics, Inc. (NYSE:SFE) stock with a Mkt Perform recommendation, according to their flash note issued to investors on December 07. Analysts at Barrington Research, made their first call for the equity with a Outperform recommendation, according to a research note that dated back to July 21.
SFE equity has an average rating of 2.33, with the figure leaning towards a bullish end. 3 analysts who tracked the company were contacted by Reuters. Amongst them, 1 rated the stock as a hold while the remaining 2 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 2 analysts rated Safeguard Scientifics, Inc. (NYSE:SFE) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.